June 12, 2016

Q3 Medical Devices Receives Financing From Norgine Ventures

June 13, 2016—Q3 Medical Devices Ltd. announced that it has received financing of up to €5 million from Norgine Ventures. Norgine Ventures is an entity of the Norgine BV group, which is a European specialist pharmaceuticals company headquartered in Amsterdam, The Netherlands.

According to the company, the funding will help Q3 Medical finance its development pipeline and grow its commercial sales. Q3 Medical Devices is an Ireland-based holding company with multiple operations in Germany focused on the development, manufacturing, and distribution of minimally invasive devices for the treatment of patients with coronary, peripheral vascular, and nonvascular diseases.

Q3 Medical’s two subsidiaries in Germany are QualiMed Innovative Medizinprodukte GmbH and AMG International GmbH. QualiMed is focused in the areas of biodegradable products, drug-device combination technologies, catheters, and mechanical implant areas. AMG develops, manufactures, and sells stents, stent implantation systems, and balloon catheters, which are used primarily in interventional cardiology.

Subscribe to our weekly newsletter.

Stay informed on the week's top stories including literature summaries, device approvals, guideline changes, and more. Plus, get our latest issues & supplements delivered to your inbox each month.

June 12, 2016

Q3 Medical Devices Receives Financing From Norgine Ventures

Current Issue

Keep In Touch